InvestorsHub Logo
Followers 59
Posts 18522
Boards Moderated 0
Alias Born 11/29/2006

Re: None

Wednesday, 05/08/2019 5:25:46 PM

Wednesday, May 08, 2019 5:25:46 PM

Post# of 8025
Tue - 13:34 Vericel analyst commentary at Oppenheimer Vericel price target raised to $32 from $23 at Oppenheimer. Oppenheimer analyst Kevin Degeeter raised his price target on Vericel (VCEL) to $32 from $23 after the company reported Q1 results, raised its 2019 revenue guidance and announced a deal to license North American rights for NexoBrid from MediWound (WDWD). He keeps an Outperform rating on Vericel shares.

Read more at:
https://thefly.com/landingPageNews.php?id=2904971
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VCEL News